Centre intégré universitaire de santé et de services sociaux de l’Ouest-de-l’Île-de-Montréal
Accueil Plan du site Courrier Portail Québec Passer directement au contenu

Bruno Giros, PhD
Photo

Researcher, Douglas Institute
Director, Schizophrenia and neurodevelopmental disorders research theme, Douglas Institute
Professor, Department of Psychiatry, McGill University
Graham Boeckh Chair in Schizophrenia, Douglas Institute
Canada Research Chair in Neurobiology of Mental Disorders


bruno_dot_giros_At_mcgill_dot_ca
Publications

2008

Bouvrais-Veret C., Weiss S., Hanoun N., Andrieux A., Schweitzer A., Job D., Hamon M., Giros B., Martres M. P. (2008). Microtubule-associated STOP protein deletion triggers restricted changes in dopaminergic neurotransmission, J Neurochem, 104(3), 745-56.

Gras C., Amilhon B., Lepicard E. M., Poirel O., Vinatier J., Herbin M., Dumas S., Tzavara E. T., Wade M. R., Nomikos G. G., Hanoun N., Saurini F., Kemel M. L., Gasnier B., Giros B., El Mestikawy S. (2008). The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone, Nat Neurosci, 11(3), 292-300.

Herzog C. J., Miot S., Mansuy I. M., Giros B., Tzavara E. T. (2008). Chronic valproate normalizes behavior in mice overexpressing calcineurin, Eur J Pharmacol, 580(1-2), 153-60.

Kashani A., Lepicard E., Poirel O., Videau C., David J. P., Fallet-Bianco C., Simon A., Delacourte A., Giros B., Epelbaum J., Betancur C., El Mestikawy S. (2008). Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease, Neurobiol Aging, 29(11), 1619-30.

Mathieu F., Miot S., Etain B., El Khoury M. A., Chevalier F., Bellivier F., Leboyer M., Giros B., Tzavara E. T. (2008). Association between the PPP3CC gene, coding for the calcineurin gamma catalytic subunit, and bipolar disorder, Behav Brain Funct, 4, 2.

Moutsimilli L., Farley S., El Khoury M. A., Chamot C., Sibarita J. B., Racine V., El Mestikawy S., Mathieu F., Dumas S., Giros B., Tzavara E. T. (2008). Antipsychotics increase vesicular glutamate transporter 2 (VGLUT2) expression in thalamolimbic pathways, Neuropharmacology, 54(3), 497-508.

Nosten-Bertrand M., Kappeler C., Dinocourt C., Denis C., Germain J., Phan Dinh Tuy F., Verstraeten S., Alvarez C., Metin C., Chelly J., Giros B., Miles R., Depaulis A., Francis F. (2008). Epilepsy in Dcx knockout mice associated with discrete lamination defects and enhanced excitability in the hippocampus, PLoS ONE, 3(6), e2473.

Ruel J., Emery S., Nouvian R., Bersot T., Amilhon B., Van Rybroek J. M., Rebillard G., Lenoir M., Eybalin M., Delprat B., Sivakumaran T. A., Giros B., El Mestikawy S., Moser T., Smith R. J., Lesperance M. M., Puel J. L. (2008). Impairment of SLC17A8 encoding vesicular glutamate transporter-3, VGLUT3, underlies nonsyndromic deafness DFNA25 and inner hair cell dysfunction in null mice, Am J Hum Genet, 83(2), 278-92.

Vialou V., Balasse L., Callebert J., Launay J. M., Giros B., Gautron S. (2008). Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice, J Neurochem, 106(3), 1471-82.

<< Back to Bruno Giros 's profile
Sort by :
By year :
  2015
  2014
  2013
  2012
  2011
  2010
  2009
  2008

[+] view more

The future of neuroscience research in mental health: a 2008 lecture by Bruno Giros (in French)
path
send
share
share